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Table 1 of this paper published in the January 2015 issue contains several errors. The Derp1 peptide comes from the Der p1 protein of
Dermatophagoides pteronyssinus not the Der f1 protein of Dermatophagoides farinae. The sequence of the MOG peptide in the I-Ab
tetramer used in the study was GWYRSPFSRVV not GWYRSPFSRVVVHLY. Themost likely 9 amino acid core register for the OVA2C
peptide in the I-Ab tetramer used in the study is VHAAHAEIN not AVHAAHAEI, which is the secondmost likely. Themost likely register
has a different number of predicted self peptide homologs than the second most likely one, which changed the x axis value for
the OVA2C peptide in Figure 4G. However, neither the level of statistical significance of the correlation between the number of
self peptide homologs and the number of naive cells specific for foreign peptides shown in Figure 4G nor the conclusion that
‘‘TCR cross-reactivity on self-peptide homologs plays some role in determining the size of MHCII-bound foreign peptide-specific
CD4+ T cell populations’’ were changed. Thus, none of these errors affect any of the conclusions of the paper. The authors deeply
regret these errors and apologize for them. Corrected versions of the table and figure appear here.Table 1. Sequence of Peptides in I-Ab Tetramers
Peptide Sequence
ESAT6 QQWNFAGIEAAASA
FliC VQNRFNSAITNLGNT
STM1540-3# VYYTTYAPQAT
STM1540-1# YTTYAPQATSA
eGFP HDFFKSAMPEGYVQE
OVA3C# GHAAHAEINEA
RplF FVSPAAHII
OVA2C# QAVHAAHAEIN
3K EAQKAKANKAVDKA
Calnexin LVVKNPAAHHAIS
AasF VSSPAVQES
1G1W EAGGALANWAVDSA
LLO# NEKYAQAYPNVS
Derp1 CQIYPPNVNKI
Cda2 HQYMTALSNEVVF
PmpG-1 YVDPAAAGG
CTB NNKTPHAIAAIS
GP66 DIYKGVYQFKSV
2W EAWGALANWAVDSA
CD4Ag28m VEIHRPVPGTA
2W109# EYWGPLPNWV
MOG# GWYRSPFSRVV1212 Immunity 42, 1212–1214, June 16, 2015 ª2015 Elsevier Inc.
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